PCSK9 Coverage: Payers Wrestling With Proving Statin Intolerance
Executive Summary
Confirmation of statin intolerance is likely to be among extensive prior authorization requirements that must be satisfied before payers approve coverage for the new class of cholesterol-lowering drugs.